Observation of preliminary clinical effect and analysis of perioperative complications of radical rostatectomy for patients with oligometastatic prostate cancer

李高翔; 戴　波; 叶定伟

doi:10.19401/j.cnki.1007-3639.2017.01.004

您当前的位置：

首页 >

文章列表页 >

Observation of preliminary clinical effect and analysis of perioperative complications of radical rostatectomy for patients with oligometastatic prostate cancer

更新时间：2025-12-31

- Observation of preliminary clinical effect and analysis of perioperative complications of radical rostatectomy for patients with oligometastatic prostate cancer
- China Oncology Vol. 27, Issue 1, Pages: 20-25(2017)
- 作者机构：
  
  复旦大学附属肿瘤医院泌尿外科，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2017.01.004
  CLC：
- Published Online：23 February 2017，
  
  Published：23 February 2017
- 稿件说明：
移动端阅览
李高翔,戴　波,叶定伟,等. 寡转移性前列腺癌根治术的临床初步疗效观察及围手术期并发症分析[J]. 中国癌症杂志, 2017, 27(1): 20-25.

李高翔, 戴　波, 叶定伟. Observation of preliminary clinical effect and analysis of perioperative complications of radical rostatectomy for patients with oligometastatic prostate cancer[J]. China Oncology, 2017, 27(1): 20-25.
李高翔,戴　波,叶定伟,等. 寡转移性前列腺癌根治术的临床初步疗效观察及围手术期并发症分析[J]. 中国癌症杂志, 2017, 27(1): 20-25. DOI： 10.19401/j.cnki.1007-3639.2017.01.004.

李高翔, 戴　波, 叶定伟. Observation of preliminary clinical effect and analysis of perioperative complications of radical rostatectomy for patients with oligometastatic prostate cancer[J]. China Oncology, 2017, 27(1): 20-25. DOI： 10.19401/j.cnki.1007-3639.2017.01.004.

摘要

背景与目的：多项回顾性研究显示，寡转移性前列腺癌根治术可以提高肿瘤的局部控制率和患者的总生存受益，围手术期并发症是影响寡转移性前列腺癌患者行前列腺癌根治术的一个重要因素。该研究旨在探讨寡转移性前列腺癌患者行前列腺癌根治术的临床初步疗效及围手术期并发症发生率和严重程度。方法：收集2015年7月—2016年1月247例前列腺癌根治术患者数据，其中寡转移性前列腺癌患者25例，局限性前列腺癌患者222例。两组均采用Clavien-Dindo手术并发症分级标准对出现并发症的患者进行分级。观察前列腺特异性抗原(prostate specific antigen，PSA)下降比例并将并发症发生率与严重程度在寡转移组和非寡转移组间进行对比分析。结果：寡转移组术后3个月时21例(84.0%)出现下降PSA

下降比例低于局限组212例(95.5%)，差异有统计学意义(P0.05)。寡转移组共6例(24.0%)患者发生术后并发症，其中严重并发症(Ⅲ度及以上)1例(4.0%)，局限组共49例(22.1%)患者发生术后并发症，其中严重并发症(Ⅲ度及以上)7例(3.2%)，差异无统计学意义(P＞0.05)。结论：寡转移性前列腺癌患者行前列腺癌根治术治疗是安全、有效和可行的，并发症风险并非寡转移性前列腺癌患者行前列腺癌根治术的限制因素。

Abstract

Background and purpose: It has been demonstrated that radical prostatectomy for patients with oligometastatic prostate cancer may contribute to improving local control of prostate cancer and overall survival by several retrospective studies. Perioperative complications play an important role in determining whether radical prostatectomy is appropriate for patients with oligometastatic prostate cancer. This study aimed to discuss the recurrence rate and the severity of perioperative complications

and the primary curative effect of radical prostatectomy on oligometastatic prostate cancer patients. Methods: A total number of 247 patients who received radical prostatectomy were recruited in the study from Jul. 2015 to Jan. 2016

including 25 patients with oligometastatic prostate cancer and 222 patients with localized prostate cancer. Patients with perioperative complications in both groups were graded with the Clavien-Dindo grading system. The proportion of PSA decline and the rates and severity of perioperative complications were analyzed in both groups. Results: The cases of prostate specific antigen (PSA) decline in the oligometastatic group were 21 (84.0%)

lower than the localized group with 212 cases (95.5%). There were 6 cases (24.0%) with postoperative complications in the oligometastatic group

including serious complications (Ⅲ or above) 1 case (4.0%)

and 49 cases (22.1%) with postoperative complications in the localized group

including serious complications (Ⅲ or above) 7 cases (3.2%). The differences between the groups reached no statistical significance (P0.05). Conclusion: Radical prostatectomy for patients with oligometastatic prostate cancer could be safe

effective

and appropriate

the risk of perioperative complications should not be one of the limiting factors.

关键词

Keywords

references

Views

2821

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Prevention and treatment of post-prostatectomy incontinence

Mechanism study of MYC promoting proliferation and metastasis in prostate cancer by targeting CD47

Interpretation of the 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: progress in external beam radiotherapy (EBRT) for differentiated thyroid cancer

The research on construction of the spontaneous prostate tumor and breast cancer model of Pten^fl/fl;Trp53^fl/fl;Pbsn-iCre⁺ transgenic mouse

Chinese expert consensus on perioperative integrated rehabilitation for radical prostatectomy (2024 edition)

Related Author

常坤

戴波

Hao LIU

Junjie SU

Shiyong XIN

Xiaoliang LIU

Xiaorong HOU

Jiachen WU

Related Institution

Department of Urology, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology

College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology

Department of Radiation Oncology, Peking Union Medical College Hospital & Chinese Academy of Medical Sciences

Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

College of Life Sciences, Inner Mongolia University, Hohhot 010000, Inner Mongolia Autonomous Region

AI问答

⁰